Bio Sequence

Biological Glossary | What is Probe?

5 December 2023
2 min read

A probe, in the scientific context of genomics and molecular biology, refers to a small, single-stranded molecule of DNA or RNA designed for hybridising with a specific section of the genome. This probe is synthesized as a complementary sequence to the part of the genome of interest, facilitating its hybridisation with the target sequence when combined. To enable easy detection and location, probes are commonly modified to either fluoresce or be radioactively labeled. They are utilized in various clinical genomic tests, including fluorescent in situ hybridisation, quantitative PCR, and microarrays. Importantly, probes play a pivotal role in genetic research, allowing scientists to track where the DNA binds in a cell, chromosome, or even in isolated DNA by attaching a label to them. They are instrumental in probing for the presence of specific proteins, screening the genome for abnormalities, and identifying where certain mRNAs are expressed in a cell or tissue. 

Free registration is available for the Bio biological sequence database: https://bio-patsnap-com.libproxy1.nus.edu.sg. Act now to expedite your sequence search tasks.

图片包含 图示

描述已自动生成

What are FAK inhibitors and how do you quickly get the latest development progress?
What are FAK inhibitors and how do you quickly get the latest development progress?
5 December 2023
FAK, or Focal Adhesion Kinase, is a crucial protein involved in various cellular processes within the human body.
Read →
Can research standards be appropriately lowered for drugs that be granted priority review designation?
Knowledge Base
2 min read
Can research standards be appropriately lowered for drugs that be granted priority review designation?
5 December 2023
Priority review is intended to expedite the FDA's review of new drugs and vaccines that have the potential to offer significant improvements over available therapies for serious conditions.
Read →
An analysis of Benmelstobart's R&D progress and its clinical results presented at the 2023 AACR Annual Meeting
An analysis of Benmelstobart's R&D progress and its clinical results presented at the 2023 AACR Annual Meeting
5 December 2023
On 15 Apr 2023, the updated PFS & OS from the interim analysis (data cutoff Oct 14, 2021) of the study (NCT03910127) was reported at the AACR Congress, illustrating its potential clinical benefits and setting the stage for further exploration.
Read →
What policies does FDA issued to accelerate the process of drug marketing?
"What" Series
2 min read
What policies does FDA issued to accelerate the process of drug marketing?
5 December 2023
FDA has implemented several policies and programs to accelerate the process of drug marketing
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.